Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data
Loomba, Rohit, Wong, Robert, Fraysse, Jeremy, Shreay, Sanatan, Li, Suying, Harrison, Stephen, Gordon, Stuart C.
Published in Alimentary pharmacology & therapeutics (01.06.2020)
Published in Alimentary pharmacology & therapeutics (01.06.2020)
Get full text
Journal Article
Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study
Salles, Gilles, Schuster, Stephen J, de Vos, Sven, Wagner-Johnston, Nina D, Viardot, Andreas, Blum, Kristie A, Flowers, Christopher R, Jurczak, Wojciech J, Flinn, Ian W, Kahl, Brad S, Martin, Peter, Kim, Yeonhee, Shreay, Sanatan, Will, Matthias, Sorensen, Bess, Breuleux, Madlaina, Zinzani, Pier Luigi, Gopal, Ajay K
Published in Haematologica (Roma) (01.04.2017)
Published in Haematologica (Roma) (01.04.2017)
Get full text
Journal Article
Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial
Ghia, Paolo, Coutre, Steven E, Cheson, Bruce D, Barrientos, Jacqueline C, Hillmen, Peter, Pettitt, Andrew R, Zelenetz, Andrew D, Shreay, Sanatan, Hallek, Michael, Furman, Richard R
Published in Haematologica (Roma) (01.10.2020)
Published in Haematologica (Roma) (01.10.2020)
Get full text
Journal Article
Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial
Montillo, Marco, Illés, Árpád, Robak, Tadeusz, Pristupa, Alexander S, Wach, Malgorzata, Egyed, Miklós, Delgado, Julio, Jurczak, Wojciech, Morschhauser, Franck, Schuh, Anna, Eradat, Herbert, Shreay, Sanatan, Barrientos, Jacqueline C, Zelenetz, Andrew D
Published in Health and quality of life outcomes (15.11.2019)
Published in Health and quality of life outcomes (15.11.2019)
Get full text
Journal Article
Comorbidities Among US Patients With Prevalent HIV Infection—A Trend Analysis
Gallant, Joel, Hsue, Priscilla Y., Shreay, Sanatan, Meyer, Nicole
Published in The Journal of infectious diseases (15.12.2017)
Published in The Journal of infectious diseases (15.12.2017)
Get full text
Journal Article
High Costs of Dialysis Transportation in the United States: Exploring Approaches to a More Cost-effective Delivery System
Stephens, J. Mark, Brotherton, Samuel, Dunning, Stephan C., Emerson, Larry C., Gilbertson, David T., Gitlin, Matthew, McClellan, Ann C., McClellan, William M., Shreay, Sanatan
Published in Journal of health economics and outcomes research (Online) (28.08.2013)
Published in Journal of health economics and outcomes research (Online) (28.08.2013)
Get full text
Journal Article
Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis
Das, Moupali, Ting, Jie, Shreay, Sanatan, Bush, Staci
Published in Annals of internal medicine (15.09.2020)
Published in Annals of internal medicine (15.09.2020)
Get more information
Journal Article
RACIAL AND ETHNIC DIFFERENCES IN CARDIOVASCULAR OUTCOMES IN PATIENTS DIAGNOSED WITH HYPERTROPHIC CARDIOMYOPATHY
Reza, Nosheen, Batra, Kirti, Amos, Qiana, Buikema, Ami, Anderson, Amy, Butzner, Michael, Shreay, Sanatan, Owens, Anjali Tiku
Published in Journal of the American College of Cardiology (02.04.2024)
Published in Journal of the American College of Cardiology (02.04.2024)
Get full text
Journal Article
Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy
Petta, Salvatore, Ting, Jie, Saragoni, Stefania, Degli Esposti, Luca, Shreay, Sanatan, Petroni, Maria Letizia, Marchesini, Giulio
Published in Nutrition, metabolism, and cardiovascular diseases (09.06.2020)
Published in Nutrition, metabolism, and cardiovascular diseases (09.06.2020)
Get full text
Journal Article
Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain
Romero-Gomez, Manuel, Kachru, Nandita, Zamorano, Meritxell Ascanio, Darba, Josep, Shreay, Sanatan
Published in Medicine (Baltimore) (11.12.2020)
Published in Medicine (Baltimore) (11.12.2020)
Get full text
Journal Article
1529-P: Higher Rates of Disease Progression among Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) Patients with Advanced Fibrosis (AF) and Diabetes Mellitus (DM)
YOUNOSSI, ZOBAIR, KACHRU, NANDITA, SHREAY, SANATAN, LOOMBA, ROHIT
Published in Diabetes (New York, N.Y.) (01.06.2019)
Published in Diabetes (New York, N.Y.) (01.06.2019)
Get full text
Journal Article
THU-299-Increased risk of mortality with liver disease progression in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients: An analysis of French national hospital care
Boursier, Jerome, Fraysse, Jeremy, Lafuma, Antoine, Fabron, Cecile, Sanatan, Shreay
Published in Journal of hepatology (01.04.2019)
Published in Journal of hepatology (01.04.2019)
Get full text
Journal Article
The prognostic value of peak oxygen uptake in obstructive hypertrophic cardiomyopathy: a literature review to inform economic model development
Butzner, Michael, Kinyik-Merena, Csilla, Aguiar, Magda, Davison, Niall, Shreay, Sanatan, Masri, Ahmad
Published in Journal of medical economics (31.12.2024)
Published in Journal of medical economics (31.12.2024)
Get full text
Journal Article
Abstract 14644: Healthcare Resource Utilization and Economic Burden Due to Atrial Fibrillation in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: Real-World Analysis of 2016-2021 Claims Data
Butzner, Michael, Sen, Sounok, Stendahl, John C, Papademetriou, Eros, Potluri, Ravi, Liu, Xing, Heitner, Stephen B, Jacoby, Daniel L, Shreay, Sanatan, Sohn, Regina L, Freeman, James V
Published in Circulation (New York, N.Y.) (07.11.2023)
Published in Circulation (New York, N.Y.) (07.11.2023)
Get full text
Journal Article
THU-308-More than 4 times higher healthcare costs for end-stage liver disease patients with non-alcoholic fatty liver disease/nonalcoholic steatohepatitis
Gordon, Stuart C, Kachru, Nandita, Sanatan, Shreay, Martinez, Diane, Moynihan, Meghan, Wong, Robert
Published in Journal of hepatology (01.04.2019)
Published in Journal of hepatology (01.04.2019)
Get full text
Journal Article
SAT-078-Characterizing compensated cirrhosis patients with potential etiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Findings from large Italian administrative databases
Reggiani, Giulio Marchesini, Ting, Jie, Saragoni, Stefania, Perrone, Valentina, Sanatan, Shreay, Petta, Salvatore
Published in Journal of hepatology (01.04.2019)
Published in Journal of hepatology (01.04.2019)
Get full text
Journal Article
Editorial: how widespread and serious is non‐alcoholic fatty liver disease in the real world? Authors' reply
Loomba, Rohit, Wong, Robert, Fraysse, Jeremy, Shreay, Sanatan, Li, Suying, Harrison, Stephen, Gordon, Stuart C.
Published in Alimentary pharmacology & therapeutics (01.06.2020)
Published in Alimentary pharmacology & therapeutics (01.06.2020)
Get full text
Journal Article